CN¥ 6.5
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Founded in 2007 and headquartered in Shenzhen, China, Shenzhen Bioeasy Biotechnology Co., Ltd. specializes in the development and commercialization of rapid testing instruments and reagents throughout the Chinese market. The company's comprehensive diagnostic equipment addresses a wide array of applications, spanning food and agricultural analysis, dairy, meat, and aquatic product testing, honey quality control, drug detection, public safety measures, and clinical diagnostics.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITD.
Data is available to registered users only